Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.
We are reimagining medicine to power breakthrough innovation in cell and gene therapy
Novartis stands behind Zolgensma® for the treatment of children less than 2 years of age with spinal muscular atrophy.
How can digital help in the fight against malaria? Bertrand Bodson, our Chief Digital Officer, shares his own exper… https://t.co/6g6JFrFG8w
[email protected] of the Novartis Foundation and @SteveDavisPATH on how we can achieve #HealthForAll by making digital t… https://t.co/d4rTCYqTSI
#BreakingNews: Novartis receives FDA priority review for investigational biologic therapy for the prevention of… https://t.co/k5LrYrQhpK
This site is intended for a global audience.